harpoontx.com (HARP): Rasio rega marang prakiraan pendapatan

Harpoon Therapeutics (HARP) is developing targeted oncology therapies via the TriTAC system, leveraging support from major pharmaceutical partners and strict temperature control during drug delivery. The projected P/S value on the GURU.Markets chart reflects liquidity dynamics, where the current figure stands at 13.20. A flawless image and institutional trust have been established for the brand following its merger with an industry behemoth.

HARP Harpoon Therapeutics Inc: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 04.07.2022 - 16.03.2024

Rincian analitis perusahaan Harpoon Therapeutics Corp (HARP)

- rega saham lan target rega konsensus:

Kutipan saham Harpoon Therapeutics, Inc.|HARP - Prakiraan konsensus analis

- data kapitalisasi bursa:

Nilai pasar Harpoon Therapeutics Corp|HARP - Nilai Bisnis

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Harpoon Therapeutics|HARP - Ekuitas Perusahaan|Rasio Kapitalisasi marang Aset Bersih harpoontx.com|HARP - Aset Neraca Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Total Utang marang Ekuitas Harpoon Therapeutics|HARP - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Harpoon Therapeutics|HARP - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Harpoon Therapeutics Corp|HARP - Utang jangka dawa|Utang jangka cendhak perusahaan Harpoon Therapeutics|Rasio cepet harpoontx.com

- data bathi bisnis lan rasio investasi:

HARP - Bathi resik|Bathi sing dikarepake Harpoon Therapeutics|HARP - Kapitalisasi marang bathi resik|Prakiraan rega marang bathi Harpoon Tx|HARP - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Harpoon Therapeutics Corp|HARP - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Harpoon Therapeutics|HARP - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan harpoontx.com|HARP - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Harpoon Therapeutics

- rincian pendapatan lan dodolan:

HARP - Pendapatan tahunan perusahaan|Prakiraan pendapatan perusahaan Harpoon Therapeutics, Inc.|HARP - Rega marang dodolan|Rasio rega marang prakiraan pendapatan Harpoon Therapeutics Corp

Ringkesan analisis perusahaan:Harpoon Therapeutics, Inc. HARP

Produk sing diprodhuksi Harpoon Therapeutics Corp

Amid high uncertainty surrounding immuno-oncology clinical trials and a liquidity crunch, Harpoon Therapeutics (HARP) is critically dependent on market expectations for future sales. The ratio of projected market capitalization to expected revenue measures the premium investors are willing to pay for the potential success of the drugs, allowing forward EV/Revenue to distinguish fundamental revaluation from speculative hype.

Analisis pesaing

ImmunityBio - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Immunocore Holdings IMCR|JANX - Rasio rega marang prakiraan pendapatan|RCUS (Arcus Corp) - Kapitalisasi marang prakiraan pendapatan|Zymeworks Inc. (ZYME) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tangotx.com (TNGX)|Multiplikator forward rega marang pendapatan IOVA|IMTX - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan XNCR (Xencor Corp)|Rasio rega marang pendapatan sing dikarepake CMPX|Multiplikator Forward P/S REPL (Replimune Group, Inc.)|Rega forward marang dodolan LYEL|Innate Pharma - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Pyxis Oncology, Inc.|cgen.com (CGEN) - Rasio rega marang prakiraan pendapatan|IO Biotech Inc. - Rega forward marang dodolan|STRO (Sutro Biopharma, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S minktherapeutics.com|Rasio rega marang prakiraan pendapatan Werewolf Therapeutics (HOWL)|IMMX: Rega mangsa ngarep marang pendapatan|ALX Oncology Holdings - Multiplikator forward rega marang pendapatan|cuebiopharma.com (CUE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|PDS Biotechnology Corp - Multiplikator Forward P/S|Rega forward marang dodolan SONN (Sonnet BioTherapeutics)|MAIA: Multiplikator Forward P/S|Liminatus Pharma Inc. (LIMN) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan LAVA Therapeutics NV|NXTC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Leap Therapeutics, Inc. (LPTX)|INTS: Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Sensei Biotherapeutics, Inc. SNSE|Theriva Biologics Inc (TOVX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GRTS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Kineta Corp|NexImmune, Inc. (NEXI) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan TSBX|Multiplikator forward rega marang pendapatan VCNX